Andere talen Bal Pharma Limited NSE India S.E.

Aandelen

BALPHARMA

INE083D01012

Beurs gesloten - NSE India S.E. Andere beurzen 13:43:51 31-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
114,6 ^INR	-5,48%		+14,65%	+14,59%

28/05	Bal Pharma Limited beveelt dividend aan	CI
28/05	Bal Pharma Limited rapporteert resultaten voor het vierde kwartaal en het volledige jaar eindigend op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Bal Pharma Limited Recommends Dividend	28/05
Bal Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	28/05
Bal Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02
Bal Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	08/11
Bal Pharma Limited Approves Dividend	25-09-23
Yearly payment	18-09-23	FA
Bal Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11-08-23
Bal Pharma Limited Appoints Abdul Basith as Company Secretary and Compliance Officer	17-07-23
Bal Pharma Limited Appoints Nicola Neeladri as Additional Director	01-06-23
Bal Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2023	29-05-23
Bal Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	29-05-23
Bal Pharma Limited Recommends Dividend	29-05-23
Bal Pharma Limited Announces Resignation of Mrs.Preeti Singh as Company Secretary	15-05-23
Bal Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	06-02-23
Bal Pharma Limited Reports Earnings Results for the Half Year Ended September 30, 2022	14-11-22
Bal Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14-11-22
Bal Pharma Limited Declares Dividend	19-09-22
Yearly payment	13-09-22	FA
Bal Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	11-08-22
Bal Pharma Limited Appoints Kotian Chittananda Damodar as Additional Director (Non Independent)	30-05-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Bal Pharma Limited NSE India S.E.

Aandelen

BALPHARMA

INE083D01012

Andere talen

Filters